Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL
ClinicalTrials.gov study NCT00072007. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dietary Intervention With High Phenolic EVOO in CLL
ClinicalTrials.gov study NCT04215367. IPD Sharing: NO. Countries: 1. Publications: 14.
Observational Study in CLL Patients Receiving BR
ClinicalTrials.gov study NCT02381899. IPD Sharing: NO. Countries: 1. Publications: 2.
Personalized Multi-peptide Vaccination in CLL Patients
ClinicalTrials.gov study NCT04688385. IPD Sharing: Not stated. Countries: 1. Publications: 2.
The Duration of Humoral Immunity and the Memory Cell Function After Vaccination With 7-valent Pneumococcal Conjugate Vaccine in CLL
ClinicalTrials.gov study NCT00919321. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00614042. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax
ClinicalTrials.gov study NCT04501939. IPD Sharing: NO. Countries: 1. Publications: 1.
Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL
ClinicalTrials.gov study NCT03708003. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT05023980. IPD Sharing: NO. Countries: 20. Publications: 0.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
ClinicalTrials.gov study NCT01081015. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Economic Analysis of Alliance A041202 CLL Study
ClinicalTrials.gov study NCT02414022. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)
ClinicalTrials.gov study NCT00779883. IPD Sharing: Not stated. Countries: 1. Publications: 51.
Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP
ClinicalTrials.gov study NCT00564512. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00391066. IPD Sharing: Not stated. Countries: 23. Publications: 4.
A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT03328273. IPD Sharing: YES. Countries: 2. Publications: 1.
CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
ClinicalTrials.gov study NCT00586391. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Prospective, Multicenter, Phase-II Trial of Ibrutinib Plus Venetoclax in Patients With Creatinine Clearance >= 30 ml/Min Who Have Relapsed or Refractory Chronic Lymphocytic Leukemia (RR-CLL) With or
ClinicalTrials.gov study NCT03226301. IPD Sharing: NO. Countries: 6. Publications: 3.
Acalabrutinib and Venetoclax Treatment of Newly Diagnosed Patients With CLL at High Risk of Infection or Early Treatment
ClinicalTrials.gov study NCT03868722. IPD Sharing: NO. Countries: 3. Publications: 10.
Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL
ClinicalTrials.gov study NCT00738829. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Prognostic Tool for Early Stage CLL
ClinicalTrials.gov study NCT03436524. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.